Helen Palmer

A state commission in New York today is likely to recommend closure of dozens of public hospitals to streamline health care delivery and costs. Helen Palmer reports.

The FDA has reached a new deal with pharmaceutical companies: Drug makers will now pay fees in return for a speedier review process of their TV ads. Helen Palmer reports.

A new survey says cancer patients — insured or not — are having a hard time keeping up with their treatment bills. Helen Palmer reports.

The CDC recommends flu shots for 185 million of us, but some experts question how effective they really are — and whether it's actually a good public health investment. Helen Palmer reports.

Enrollment starts today for year two of the government's Medicare Part program. Not everyone's satisfied, but it's been mostly a success for seniors — and insurers, Helen Palmer reports.

The health insurance industry's main lobby group today unveils a plan to provide access to health coverage for all Americans. Does it live up to its promise? Helen Palmer reports.

The FDA has a new plan to improve safety monitoring for medical devices like pacemakers, defibrillators and those spring-like stents that pop arteries open during surgery. Helen Palmer reports.

<strong>WEB EXTRA:</strong> Missouri voters on Tuesday approved expanding stem-cell research. The Show Me State plans to show the world it can be a stem-cell center. Helen Palmer reports.

Despite the outcome of Tuesday's ballot initiative in Missouri, the debate over embryonic stem cell research isn't likely to end soon. Meantime, funding for the research continues to grow. Helen Palmer reports.

New research out of Harvard finds mice given large amounts of a compound found in red wine were able to consume high-calorie diets without the usual bad side effects of getting fat. Helen Palmer reports.